Browsing: Conditions

“Obtaining regulatory approval is one part of the challenge for rare disease therapies. Following approval, HTA agencies and payers evaluate the clinical, economic, and patient-centered value of a therapy to inform pricing, reimbursement, and patient access decisions. Historically, rare disease trials have often relied on small patient populations, single-arm or open-label designs, surrogate endpoints, and…

Now United Kingdom, Canada, Australia and New Zealand Unite Around Growing Endometriosis Awareness as Women’s Workplace Health Crisis Reshapes Inclusive Employment Policies, Medical Advocacy and Accessible Travel Experiences – Travel And Tour World